Abstract
Metrics
Get Permission
Authors Jia TT, Sun ZG, Lu Y, Gao J, Zou H, Xie FY, Zhang GQ, Xu H, Sun DX, Yu Y, Zhong YQ
Received 17 August 2015
Accepted for publication 14 March 2016
Published 5 August 2016 Volume 2016:11 Pages 3765—3775
DOI https://dx.doi.org/10.2147/IJN.S94622
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Xian Xu
Peer reviewer comments 4
Editor who approved publication: Dr Lei Yang
Tingting Jia,1,* Zhiguo Sun,1,* Ying Lu,1 Jie Gao,1 Hao Zou,1 Fangyuan Xie,2 Guoqing Zhang,2 Hao Xu,3Duxin Sun,3 Yuan Yu,1 Yanqiang Zhong1
1Department of Pharmaceutical Sciences, School of Pharmacy, The Second Military Medical University,2Department of Pharmacy, Eastern Hepatobiliary Surgery Hospital, Shanghai, People’s Republic of China; 3Department of Pharmaceutical Sciences, School of Pharmacy, University of Michigan, Ann Arbor, MI, USA
*These authors contributed equally to this work
Abstract:
Due to the impermeability of the blood–brain barrier and the nonselective distribution of drugs in the brain, the therapeutic access to intractable neurological disorders is challenging. In this study, dual brain-targeting polymersomes (POs) functionalized by transferrin and Tet-1 peptide (Tf/Tet-1-POs) promoted the transportation of curcumin into the brain and provided neuroprotection. The modification of the ligands that bind to the surface of POs was revealed by X-ray photoelectron spectroscopy analysis. The cell uptake of a coculture model of mouse brain capillary endothelial cells with neurons showed that the Tf/Tet-1-POs had significant transportation properties and possessed affinity for neurons. The pharmacokinetic analysis showed that the blood–brain barrier permeability–surface efficiency of the Tf/Tet-1-POs was 0.28 mL/h/g and that the brain tissue uptake rate (% ID/g) was 0.08, which were significant compared with the controls (P<0.05). The curcumin-encapsulated Tf/Tet-1-POs provided neuroprotection and ameliorated cognitive dysfunction in intrahippocampal amyloid-β1–42-injected mice. These results suggest that the dual brain-targeting POs are more capable of drug delivery to the brain that can be exploited as a multiple noninvasive vehicle for targeting therapeutics.
Keywords: polymersomes, transferrin, Tet-1 peptide, Alzheimer’s disease

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Download Article [PDF]
Keywords: polymersomes, transferrin, Tet-1 peptide, Alzheimer’s disease

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Download Article [PDF]
This integrates curcumin and NanoViricides developments!
ReplyDelete